WisdomTree BioRevolution Fund Rating $20.27 +0.42 (+2.12%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.69Holdings in WDNA have an aggregate rating of Moderate Buy based on 443 analyst ratings issued in the past year covering 24 companies (55.4% of the portfolio).WDNA Aggregate Price Target$20.27High Prediction$20.27Average Prediction$20.27Low Prediction$20.27Holdings in WDNA have an aggregate price target of $20.27 and a range of $20.27 to $20.27 covering 24 companies (55.4% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 WDNA Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.27%TWSTTwist Bioscience$99.84+3.3%1.4079 of 5 stars2.80$74.60 -25.3%10Analyst ForecastInsider TradeHigh Trading Volume4.33%LLYEli Lilly and Company$1,206.51+7.0%4.1263 of 5 stars2.87$1,235.07 2.4%30Trending NewsDividend AnnouncementAnalyst ForecastOptions VolumeHigh Trading Volume3.48%MRNAModerna$67.27+12.6%0.978 of 5 stars1.83$37.13 -44.8%18Trending NewsAnalyst Forecast3.11%JNJJohnson & Johnson$254.64+4.0%4.4273 of 5 stars2.74$256.70 0.8%27Trending NewsAnalyst Forecast2.80%UTHRUnited Therapeutics$542.66-0.1%4.4987 of 5 stars2.85$619.42 14.1%13Insider Trade2.32%TEMTempus AI$56.14+2.3%3.0686 of 5 stars2.50$68.54 22.1%14Options Volume2.24%DARDarling Ingredients$52.48-1.1%4.508 of 5 stars2.92$67.45 28.5%13Analyst Forecast2.17%IMNMImmunome$19.96+2.9%3.0386 of 5 stars2.85$33.17 66.2%13High Trading Volume2.16%STOKStoke Therapeutics$32.00+5.3%2.1746 of 5 stars2.73$41.83 30.7%11Positive NewsHigh Trading Volume2.13%BEAMBeam Therapeutics$34.81+2.6%2.0729 of 5 stars2.71$46.83 34.5%14High Trading Volume2.09%NTRANatera$261.91+0.4%1.8552 of 5 stars2.82$259.22 -1.0%22Analyst ForecastHigh Trading Volume2.01%CTVACorteva$82.60+1.2%3.8685 of 5 stars2.61$88.81 7.5%231.96%BGBunge Global$110.41-1.0%4.4001 of 5 stars2.91$132.67 20.2%111.95%IONSIonis Pharmaceuticals$81.18+3.6%3.2736 of 5 stars2.90$102.90 26.8%21Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume1.93%KRYSKrystal Biotech$372.25+3.4%2.2785 of 5 stars2.83$340.56 -8.5%12Insider TradeHigh Trading Volume1.92%CRSPCRISPR Therapeutics$54.92+1.7%2.8799 of 5 stars2.58$67.78 23.4%19High Trading Volume1.91%GPCRStructure Therapeutics$49.71+3.0%2.5992 of 5 stars2.89$110.55 122.4%18Positive News1.71%TXG10x Genomics$36.75+2.9%1.4663 of 5 stars2.20$24.00 -34.7%15Analyst ForecastInsider TradeHigh Trading Volume1.68%AMGNAmgen$358.61+1.6%3.5933 of 5 stars2.43$354.42 -1.2%30Positive News1.67%GILDGilead Sciences$127.87+3.3%4.9821 of 5 stars2.86$158.41 23.9%29Positive NewsHigh Trading Volume1.66%ROIVRoivant Sciences$34.07+0.1%2.1088 of 5 stars2.75$33.59 -1.4%12Positive NewsInsider TradeHigh Trading Volume1.64%PFEPfizer$24.28+2.6%4.4127 of 5 stars2.25$28.82 18.7%20Trending NewsDividend AnnouncementAnalyst Forecast1.62%TMOThermo Fisher Scientific$513.54+1.5%4.8724 of 5 stars2.85$605.09 17.8%26Positive NewsAnalyst ForecastHigh Trading Volume1.62%RVMDRevolution Medicines$182.08+2.2%1.7222 of 5 stars3.00$123.72 -32.1%22Insider TradeOptions VolumeHigh Trading Volume This page (BATS:WDNA) was last updated on 6/26/2026 by MarketBeat.com Staff. From Our PartnersProblems at SpaceX: time to get out?Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredElon’s message for AmericaElon Musk bought Super Bowl ad time at $266,000 per second - something he has never done before. 125 million A...Stansberry Research | SponsoredSolar is dead. Here’s what replaces it.Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-car...Behind the Markets | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
